Search Results - "Couffin‐Cadiergues, S."

Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection by Stefic, Karl, Novelli, Sophie, Mahjoub, Nadia, Seng, Remonie, Molina, Jean-Michel, Cheneau, Christine, Barin, Francis, Chaix, Marie-Laure, Meyer, Laurence, Delaugerre, Constance

“…Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases,…”
Get full text

Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight) by Molina, Jean-Michel, Gallien, Sebastien, Chaix, Marie-Laure, El Abbassi, El Mountacer, Madelaine, Isabelle, Katlama, Christine, Valin, Nadia, Delobel, Pierre, Desseaux, Kristell, Peytavin, Gilles, Saillard, Juliette, Raffi, François, Chevret, Sylvie

“…To assess whether low-dose ritonavir-boosted darunavir (darunavir/r) in combination with two NRTIs could maintain virological suppression in patients on a…”
Get full text

Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study by Lê, Minh Patrick, Soulié, Cathia, Assoumou, Lambert, Valantin, Marc-Antoine, Duvivier, Claudine, Chas, Julie, Ponscarme, Diane, Marcelin, Anne-Geneviève, Calvez, Vincent, Katlama, Christine, Peytavin, Gilles

Get full text

Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)‐coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort] by Michel, L, Lions, C, Winnock, M, Lang, J‐P, Loko, M‐A, Rosenthal, E, Marchou, B, Valantin, M‐A, Morlat, P, Roux, P, Sogni, P, Spire, B, Poizot‐Martin, I, Lacombe, K, Lascoux‐Combe, C, Duvivier, C, Neau, D, Dabis, F, Salmon‐Ceron, D, Carrieri, MP, Salmon, D., Benhamou, Y., Trimoulet, P., Izopet, J., Paradis, V., Carrieri, P., Katlama, C., Pialoux, G., Bonnard, P, Bicart See, A., Djebbar, R., Gervais, A., Goujard, C., Vittecoq, D., BaniSadr, F., Meyer, L., Boufassa, F., Dominguez, S., Autran, B., Roque, A. M., Solas, C., Fontaine, H., Serfaty, L., Chêne, G., Costagliola, D., Couffin‐Cadiergues, S.

“…Objectives The objective of this nested study was to assess the prevalence of psychiatric disorders in a sample of HIV/hepatitis C virus (HCV)‐coinfected…”
Get full text

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records by Bertrand, Julie, Barrail-Tran, Aurélie, Fayette, Lucie, Savic, Rada, Goujard, Cécile, Teicher, Elina, Barau, Caroline, Pruvost, Alain, Taburet, Anne-Marie, Mentré, France, Verstuyft, Céline

“…Tenofovir (TFV) and emtricitabine (FTC) are part of the recommended highly active antiretroviral therapy (ART). Both molecules show a large interindividual…”
Get full text

Ensuring quality control in a clinical trial during the COVID-19 pandemic: The experience of the Inserm C20-15 DisCoVeRy study in France by Fougerou-Leurent, C., Delmas, C., Saillard, J., Dumousseaux, M., Ferrane, A., Mercier, N., Terzic, V., Le Mestre, S., Dechanet, A., Noret, M., Diallo, A., Couffin-Cadiergues, S., Esperou, H.

“…Meeting Abstract PM2-027…”
Get full text

Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies by Chaillon, Antoine, Essat, Asma, Frange, Pierre, Smith, Davey M, Delaugerre, Constance, Barin, Francis, Ghosn, Jade, Pialoux, Gilles, Robineau, Olivier, Rouzioux, Christine, Goujard, Cécile, Meyer, Laurence, Chaix, Marie-Laure

“…Characterizing HIV-1 transmission networks can be important in understanding the evolutionary patterns and geospatial spread of the epidemic. We reconstructed…”
Get full text

HIV-1 DNA Levels in Peripheral Blood Mononuclear Cells and Cannabis Use are Associated With Intermittent HIV Shedding in Semen of Men Who Have Sex With Men on Successful Antiretroviral Regimens by Ghosn, Jade, Leruez-Ville, Marianne, Blanche, Jérôme, Delobelle, Aurore, Beaudoux, Céline, Mascard, Laurence, Lecuyer, Hervé, Canestri, Ana, Landman, Roland, Zucman, David, Ponscarme, Diane, Rami, Agathe, Viard, Jean-Paul, Spire, Bruno, Rouzioux, Christine, Costagliola, Dominique, Suzan-Monti, Marie

“…Background. Few data exist on the efficacy of combined antiretroviral therapy (cART) in semen of human immunodeficiency virus type 1 (HIV-1) infected men who…”
Get full text

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone by Choi, Edward Man-Lik, Lacarra, Boris, Baiden, Frank, Hamzé, Benjamin, Schwimmer, Christine, Manno, Daniela, Keita, Cheick Mohamed, Njie, Yusupha, van Dijck, Wim, Gaddah, Auguste, Otieno, Godfrey T, Samai, Mohamed, Deen, Gibrilla Fadlu, Kowuor, Dickens, Greenwood, Brian, Mooney, T, Conteh, L, Bangura, MS, Koroma, S, Sesay, M, Kamara, A, Odeny, L, Sow, A, Conteh, M, Kanneh, M, Deen, GF, Larson, H, Tindanbil, D, Swaray, IB, Sesay, F, Manno, D, Rwezaula, R, Tuda, GO, Koroma, F, Bangura, G, Mansaray, HA, Sheku, MF, Kanu, AP, Gandie, V, Marrah, M, Kalokoh, J, Lahai, A, Bangura, M, Tengbeh, A, Kabia, R, Lee, S, Nyaberi, D, Ndingi, S, Bangura, AR, Edem-Hotah, J, Fatorma, T, Sannoh, M, Snowden, E, Howard, K, KEITA, CM, GUILAVOGUI, JPY, BAH, H, SAMOURA, MA, SEMAKUBA, B, KABA, AS, BERERD-CAMARA, M, DECHENAUD, M, CAMARA, MT, DIALLO, SD, DOUMBOUYA, N, VATRINET, R, LACARRA, B, BETARD, C, KANTE, M, SCHWIMMER, C, ESPEROU, H, Chai, SP, Buth, W, Offergeld, K, Menten, A, De Ridder, S, Sellecchia, R, in ’t Veld, R, Anumendem, D, Hoda, S, Hubin, E, Desai, J, Bennet, M, van Gils, N, Ligthart, M, Van Roey, G, van Dijck, W, Van Ballaert, S, Robinson, C, McLean, C, Kaminski, A, Vergauwen, H, DiMondi, CV, Meurer, J, Delport, C, Strydom, A, Bezem-Aviv, I, Wachnicka, A, Cheng, S, Kang, K

“…This study assessed the safety and immunogenicity of the Ad26.ZEBOV and MVA-BN-Filo Ebola virus (EBOV) vaccine regimen in infants aged 4–11 months in Guinea…”
Get full text

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients by Bastard, J.-P., Couffignal, C., Fellahi, S., Bard, J.-M., Mentre, F., Salmon, D., Katlama, C., Raffi, F., Leport, C., Capeau, J.

“…Ageing HIV-infected patients controlled by antiretroviral therapy (ART) frequently present age-related comorbidities, such as cardiovascular (CV) events,…”
Get full text

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO13‐HEPAVIH) by Vilotitch, A., Esterle, L., Spire, B., Rey, D., Carrieri, P., Salmon, D, Trimoulet, P, Izopet, J, Poizot‐Martin, I, Barange, K, Naqvi, A, Rosenthal, E, Bouchaud, O, Goujard, C, Lacombe, K, Dominguez, S, Autran, B, Roque, A.M., Boué, F, Aumaître, H, Salmon, D, Katlama, C, Stitou, H, Charlotte, F, Fourati, S, Simon, A, Cacoub, P, Pialoux, G, Bendjaballah, F, Le Pendeven, C, Marchou, B, Selves, J, Uzan, M, Ferro‐Collados, M.J, Gervais, A, Adle‐Biassette, H, Molina, J.M, Duclos, J, Palmer, P, Girard, P.M, Viala, C, Goujard, C, Pallier, C, Lortholary, O, Duvivier, C, Mélard, A, Neau, D, Cazanave, C, Dupon, M, Reigadas, S, Lacoste, D, Roger‐Schmeltz, J, Carmen Pertusa, M, Vandenhende, M, Caldato, S, Lazzaro, E, Greib, C, Bioulac‐Sage, P, Majerholc, C, Boué, F, Kansau, I, Chambrin, V, Pignon, C, Fior, R, Martinez, V, Dominguez, S, Lelièvre, J.D, Lascaux, A.S, Raffi, F, Ader, F, Biron, F, Boibieux, A, Koffi, J, Lack, P, Maynard, M, Amiri, M, Piroth, L, Chavanet, P, Waldner‐Combernoux, A, Croisier‐Bertin, D, Rouger, C, Beniken, D, Ritleng, A.‐S, Payssan, V, Breau, S, Raho‐Moussa, M, Ogoudjobi, S, Azar, M, Chesnel, C, Maradan, G, Kurkdji, P, Kmiec, I, Pietri, M.P, Guet, P, Mebarki, M, Delaune, J, Gillet, S, Jacquet, A, Protopopescu, C, Rosellini, S

“…Summary Liver steatosis is common in human immunodeficiency virus (HIV)‐hepatitis C virus (HCV)‐co‐infected patients. Some recent studies have found that…”
Get full text

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity by Bastard, Jean-Philippe, Fellahi, Soraya, Couffignal, Camille, Raffi, François, Gras, Guillaume, Hardel, Lucile, Sobel, Alain, Leport, Catherine, Fardet, Laurence, Capeau, Jacqueline

“…The objective of this study was to analyse the respective roles of personal factors and HIV infection markers on the systemic immune activation/inflammatory…”
Get full text

Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study by Lê, Minh P, Chaix, Marie-Laure, Chevret, Sylvie, Bertrand, Julie, Raffi, François, Gallien, Sébastien, El Abbassi, El Mountacer Billah, Katlama, Christine, Delobel, Pierre, Yazdanpanah, Yazdan, Saillard, Juliette, Molina, Jean-Michel, Peytavin, Gilles

“…In the ANRS 165 DARULIGHT study (NCT02384967) carried out in HIV-infected patients, the use of a darunavir/ritonavir-containing regimen with a switch to a…”
Get full text

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study by Katlama, Christine, Assoumou, Lambert, Valantin, Marc-Antoine, Soulié, Cathia, Duvivier, Claudine, Chablais, Laetitia, Kolta, Sami, Pialoux, Gilles, Mercié, Patrick, Simon, Anne, Costagliola, Dominique, Peytavin, Gilles, Marcelin, Anne-Genevieve

“…Background Novel nucleoside reverse transcriptase inhibitor- and protease inhibitor-sparing strategies are needed in long-term-treated patients with…”
Get full text

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course by Raffi, François, Le Moing, Vincent, Assuied, Alex, Habak, Sofiane, Spire, Bruno, Cazanave, Charles, Billaud, Eric, Dellamonica, Pierre, Ferry, Tristan, Fagard, Catherine, Leport, Catherine

“…We assessed factors, including treatment course, associated with failure to obtain a 10 year immunological response after starting first-generation…”
Get full text

Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort by Gelu‐Simeon, Moana, Lewin, Maïté, Ostos, Maria, Bayan, Tatiana, Beso Delgado, Maria, Teicher, Elina, Layese, Richard, Roudot‐Thoraval, Françoise, Fontaine, Hélène, Sobesky, Rodolphe, Salmon‐Céron, Dominique, Samuel, Didier, Seror, Olivier, Nahon, Pierre, Meyer, Laurence, Duclos‐Vallée, Jean‐Charles, Petrov‐Sanchez, Ventzislava, Autran, Brigitte, Boufassa, Faroudy, Bourlière, Marc, Dominguez, Stéphanie, Hézode, Christophe, Pageaux, Georges‐Philippe, Poizot‐Martin, Isabelle, Roque‐Afonso, Anne‐Marie, Samri, Assia, Vittecoq, Daniel, Dabis, F, Winnock, M, Loko, A, Sogni, P, Benhamou, Y, Trimoulet, P, Izopet, J, Paradis, V, Spire, B, Carrieri, P, Katlama, C, Pialoux, G, Valantin, A, Bonnard, P, Poizot‐Martin, I, Marchou, B, Rosenthal, E, Garipuy, D, Bouchaud, O, Gervais, A, Lascoux‐Combe, C, Goujard, C, Lacombe, K, Duvivier, C, Vittecoq, D, Neau, D, Morlat, P, BaniSadr, F, Boufassa, F, Dominguez, S, Autran, B, Roque, M, Solas, C, Serfaty, L, Chêne, G, Costagliola, D, Zucman, D, Simon, A, Dominguez, S, Billaud, E, Miailhes, P, Devoto, J, Couffin‐Cadiergues, S, Nahon, P, Mahuas‐Bourcier, V, Zucman‐Rossi, J, Bedossa, P, Laurent, A, Layese, R, Durand‐Zaleski, I, Marche, P, Thibault, V, Guyader, D, Dharancy, S, Leroy, V, Vilgrain, V, Bonjour, M, Cagnot, C, Petrov‐Sanchez, V

“…Background & Aims HIV/HCV co‐infected patients with hepatocellular carcinoma (HCC) have poorer survival than HCV mono‐infected patients. We aimed to evaluate…”
Get full text

Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) by Carrieri, Maria Patrizia, Serfaty, Lawrence, Vilotitch, Antoine, Winnock, Maria, Poizot-Martin, Isabelle, Loko, Marc-Arthur, Lions, Caroline, Lascoux-Combe, Caroline, Roux, Perrine, Salmon-Ceron, Dominique, Spire, Bruno, Dabis, Francois

“…Background. Diabetes and insulin resistance (IR) is common in human immunodeficiency virus–hepatitis C virus (HIV–HCV)-coinfected patients, a population also…”
Get full text

Nevirapine Use Is Associated with Higher Bone Mineral Density in HIV-1 Positive Subjects on Long-Term Antiretroviral Therapy by Couffignal, Camille, Kolta, Sami, Flamant, Martin, Cazanave, Charles, Haymann, Jean-Philippe, Mentré, France, Duval, Xavier, Leport, Catherine, Raffi, François

“…We assessed bone mineral density (BMD) in a cohort of human immunodeficiency virus (HIV)-positive patients after a median of 11 years of combination…”
Get more information

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia by Campillo-Gimenez, Laure, Assoumou, Lambert, Valantin, Marc-Antoine, Pajanirassa, Priyadharshini, Villemonteix, Juliette, Soulié, Cathia, Marcelin, Anne-Geneviève, Costagliola, Dominique, Capeau, Jacqueline, Autran, Brigitte, Katlama, Christine, Guihot, Amélie

“…Immunovirological consequences of a switch to a maraviroc/raltegravir dual therapy were analyzed in 16 HIV-infected patients with persistent viral load below…”
Get full text

Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study by Barau, Caroline, Braun, Joséphine, Vincent, Corine, Haim-Boukobza, Stéphanie, Molina, Jean-Michel, Miailhes, Patrick, Fournier, Isabelle, Aboulker, Jean-Pierre, Vittecoq, Daniel, Duclos-Vallée, Jean-Charles, Taburet, Anne-Marie, Teicher, Elina

“…Background. The end-stage LIVER disease and RALtegravir-Agence Nationale de Recherche sur le Sida et les hépatites (LIVERAL-ANRS) 148 study aimed to evaluate…”
Get full text